Research at Pitt

Medicine in Pittsburgh

The University of Pittsburgh Medical School is considered a top tier medical school with a focus in research ranking in the top 5 recipients of NIH funding, leading to 1301 publications and 212 NIH awards. In 2019, there were 13 funded T32/TL1 training grants in effect at the University. The revenue for research at the University of Pittsburgh has been steadily increasing to its current total of 102 million dollars. Because of its success, the University of Pittsburgh is regarded as a top tier research university, offering positions to undergraduate students, graduate students, and postdoctoral candidates. 

Working in the VMI

The Vascular Medicine Institute partnered with the UPMC Heart and Vascular Institute to form the Pittsburgh Heart, Lung, and Blood Vascular Medicine Institute in 2013. The institute functions with the goal of performing cutting edge research in hemostasis, red blood cell biophysics, transfusion medicine, cardiovascular biology, mitochondrial biology and nitrite-nitric oxide and reactive oxygen species biochemistry to expand our understanding of the control of blood flow to organ systems and the development of novel therapies for diseases such as pulmonary hypertension, sickle cell vasculopathy, atherosclerosis, hypertension and heart disease. The Vascular Medicine Institute is supported by the University of Pittsburgh, UPMC, Vitalant, and the Hemophilia Center of Western Pennsylvainia. 

Partnering with the Center for Mitochondrial Medicine

The Center for Metabolism and Mitochondrial Medicine (C3M) is an initiative supported by the University of Pittsburgh Department of Medicine’s Division of Endocrinology and Metabolism, the Division of Cardiology, and the Vascular Medicine Institute. C3M‘s mission is to facilitate and initiate research to understand the contribution of metabolism and the mitochondria in disease pathology and physiology. C3M also supports meetings like TriMAD Symposium and the Pittsburgh Lung Conference.